Despite the preventive benefit of targeting ACE2 expression in COVID-19 gateway tissues, SARS-CoV spike protein-induced downregulation of ACE2 expression may consequently play a role in acute lung failure, because ACE2 could protect mice from severe acute lung injury [28, 29]. This evidence concerns the gene ACE2 and COVID-19.